RUNX1 and neoplasm: Compared with vehicle-treated mice, tumor-bearing mice receiving Spautin-1 showed inhibited tumor formation and growth rate, which was reversed by RUNX1 overexpression (Fig. 6G and Supplementary Fig. S6D).